Atrial natriuretic peptides during experimental atrial tachycardia: Role of developing tachycardiomyopathy

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 8, 2004, Pages 927-932

  Schoonderwoerd, Bas A ^a   Crijns, Harry J G M ^b   Van Veldhuisen, Dirk J ^a   Boomsma, Frans ^c   Van Den Berg, Maarten P ^a   Bel, Klaas J ^a   Van Gelder, Isabelle C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Fibrillation; Heart failure; Natriuretic peptides; Pacing

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; GOAT; HEART ATRIUM ENLARGEMENT; HEART PACING; HEART RHYTHM; NONHUMAN; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA;

ANIMALS; ATRIAL NATRIURETIC FACTOR; FEMALE; GOATS; HEART FAILURE, CONGESTIVE; TACHYCARDIA, ECTOPIC ATRIAL; TACHYCARDIA, VENTRICULAR;

EID: 4444370942     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.04093.x     Document Type: Article

References (21)

1. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 1998;339:321-328.
2. Christensen G, Leistad E: Atrial systolic pressure, as well as stretch, is a principal stimulus for release of ANF. Am J Physiol 1997;272:H820-H826.
3. Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC Jr: Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988;62:191-195.
4. Schiebinger RJ, Li Y, Cragoe EJ Jr: Calcium dependency of frequency-stimulated atrial natriuretic peptide secretion. Hypertension 1994;23:710-716.
5. Schiebinger RJ, Linden J: Effect of atrial contraction frequency on atrial natriuretic peptide secretion. Am J Physiol 1986;251:H1095-H1099.
6. Bilder GE, Siegl PK, Schofield TL, Friedman PA: Chronotropic stimulation: A primary effector for release of atrial natriuretic factor. Circ Res 1989;64:799-805.
7. Walsh KP, Williams TD, Spiteri C, Pitts E, Lightman SL, Sutton R: Role of atrial pressure and rate in release of atrial natriuretic peptide. Am J Physiol 1988;254:R607-R610.
8. Nishimura K, Ban T, Saito Y, Nakao K, Imura H: Atrial pacing stimulates secretion of atrial natriuretic polypeptide without elevation of atrial pressure in awake dogs with experimental complete atrioventricular block. Circ Res 1990;66:115-122.
9. Burnett JC Jr, Osborn MJ, Hammill SC, Heublein DM: The role of frequency of atrial contraction versus atrial pressure in atrial natriuretic peptide release. J Clin Endocrinol Metab 1989;69:881-884.
10. Roy D, Paillard F, Cassidy D, Bourassa MG, Gutkowska J, Genest J, Cantin M: Atrial natriuretic factor during atrial fibrillation and supraventricular tachycardia. J Am Coll Cardiol 1987;9:509-514.
11. Van Den Berg MP, Crijns HJ, Van Veldhuisen DJ, Van Gelder IC, Kam PJ, Lie KI: Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation: Role of duration of atrial fibrillation. Am Heart J 1998;135:242-244.
12. Van Gelder IC, Crijns HJ, Blanksma PK, Landsman ML, Posma JL, Van Den Berg MP, Meijler FL, Lie KI: Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol 1993;72:560-566.
13. Schoonderwoerd BA, Van Gelder IC, Van Veldhuisen DJ, Tieleman RG, Grandjean JG, Bel KJ, Allessie MA, Crijns HJ: Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: Role of developing tachycardiomyopathy. J Cardiovasc Electrophysiol 2001;12:1404-1410.
14. Derkx FH, Tan-Tjiong L, Wenting GJ, Boomsma F, Man in't Veld AJ, Schalekamp MA: Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis. Hypertension 1983;5:244-256.
15. Stangl K, Weil J, Seitz K, Laule M, Gerzer R: Influence of AV synchrony on the plasma levels of atrial natriuretic peptide (ANP) in patients with total AV block. Pacing Clin Electrophysiol 1988;11:1176-1181.
16. Nishino M, Hoshida S, Tanouchi J, Ito T, Kato J, Iwai K, Tanahashi H, Hori M, Yamada Y, Kamada T: Time to recover from atrial hormonal, mechanical, and electrical dysfunction after successful electrical cardioversion of persistent atrial fibrillation. Am J Cardiol 2000;85:1451-1454.
17. Tuinenburg AE, Brundel BJ, Van Gelder IC, Henning RH, Van Den Berg MP, Driessen C, Grandjean JG, Van Gilst WH, Crijns HJ: Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:827-835.
18. Burnett JC Jr, Kao PC, Hu DC, Heser DW, Heublein D, Granger JP, Opgenorth TJ, Reeder GS: Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986;231:1145-1147.
19. Tuinenburg AE, Van Veldhuisen DJ, Boomsma F, Van Den Berg MP, de Kam PJ, Crijns HJ: Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol 1998;81:1207-1210.
20. Seino Y, Shimai S, Ibuki C, Itoh K, Takano T, Hayakawa H: Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: Endocrinologic silence. J Am Coll Cardiol 1991;18:459-463.
21. Van Den Berg MP, Tjeerdsma G, de Kam PJ, Boomsma F, Crijns HJ, Van Veldhuisen DJ: Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure. Eur J Heart Fail 2002;4:255-262.